"Our findings should be viewed as being significant but tentative, as future studies are needed to examine these questions in a much larger and more diverse population, Rizzo said
So the FDA made an announcement: Its launching what it calls a green list of GLP-1 APIs from overseas facilities that the agency has inspected or evaluated that appear to be in compliance with the FDAs rigorous standards. GLP-1s coming from other sources will be subject to detention without physical examination. Some media outlets looking at you, Axios made it sound as if this green list was all about compounded drugs (and, to be fair, the FDA did throw a little unnecessary shade on compounding)
Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics
Borchert A, Kalms J, Roth SR, Rademacher M, Schmidt A, Holzhutter H-G et al (2018) Crystal structure and functional characterization of selenocysteine-containing glutathione peroxidase 4 suggests an alternative mechanism of peroxide reduction